Drug class in one race
PPAR (pan-agonist) drugs for Type 2 Diabetes
2 tracked PPAR (pan-agonist) drugs in the Type 2 Diabetes race. The class explanation lives on the PPAR (pan-agonist) page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
1 Phase 31 Phase 2
Head-to-head evidence: Chiglitazar vs Lanifibranor